Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Yoshiharu Intends to Appeal Delisting Notice from Nasdaq
05:45pm, Friday, 21'st Feb 2025
BUENA PARK, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a restaurant operator specializing in authentic Japanese ramen & rolls, today
SaverOne Implements Change in Ratio of Shares to ADSs to Meet Nasdaq Minimum Bid Price Requirement
05:05pm, Friday, 21'st Feb 2025
Petah Tikvah, Israel, Feb. 21, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), On February 20, 2025, SaverOne 2014 Ltd. received a letter from the Listing Qualifications Depart
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 21'st Feb 2025
SAN DIEGO , Feb. 21, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide
Nauticus Robotics Regains Compliance with Nasdaq Listing Standards
04:30pm, Thursday, 20'th Feb 2025
HOUSTON , Feb. 20, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software, today announced that on February 18, 2025, it received a
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives
HYZON ANNOUNCES DELISTING FROM NASDAQ AND EXPECTED SEC DEREGISTRATION
04:22pm, Thursday, 20'th Feb 2025
BOLINGBROOK, Ill. , Feb. 20, 2025 /PRNewswire/ -- Hyzon Motors Inc. ("Hyzon" or the "Company"), a U.S.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 20'th Feb 2025
DUBLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of
HONG KONG, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex Limited” or the “Company”) (Nasdaq: DGNX), a Cayman Islands-based impact technology company specializing in environmental
Millicom (Tigo) reiterates intention to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm
09:51am, Thursday, 20'th Feb 2025
Millicom (Tigo) reiterates intention to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm Luxembourg, February 20, 2025 – As previously communicated on November 2
These Were the 5 Top-Performing Stocks in the Nasdaq-100 in January 2025
09:45am, Thursday, 20'th Feb 2025
The first full month of 2025 is in the books, and the stock market is off to a decent start. The major indexes -- the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average -- were up 2.7%, 1.6%,
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
07:30am, Thursday, 20'th Feb 2025
The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, nutraceut
NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director
06:00am, Thursday, 20'th Feb 2025
Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives
Sell these overvalued Nasdaq 100 stocks at their top
04:19am, Thursday, 20'th Feb 2025
The Nasdaq 100 index continues its strong surge this year and is now at its highest record level. It soared to a high of $22,175 on Wednesday, bringing its year-to-date gains to about 4.3%.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 19'th Feb 2025
NOVATO, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rar
iBio to Begin Trading on the Nasdaq Stock Exchange
04:05pm, Wednesday, 19'th Feb 2025
SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio's common stock has been approved for listing on
